Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Weekend Edition: More recalls for extended-release metformin | TCT Connect coverage | Valve durability after 5 years
Saturday, October 17, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Top Stories

2 new recalls announced for extended-release metformin due to contamination

More lots of extended-release metformin have been recalled due to high levels of NDMA, a contaminant associated with cancer.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

2 new recalls announced for extended-release metformin due to contamination

Share on Twitter Share on Facebook Share on Linkedin
More lots of extended-release metformin have been recalled due to high levels of NDMA, a contaminant associated with cancer.
READ MORE >

Bivalirudin bests heparin for treating heart attack patients undergoing PCI

The findings were presented Wednesday, Oct. 14, during TCT Connect 2020. 

READ MORE >
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
Share on Twitter Share on Facebook Share on Linkedin

Bivalirudin bests heparin for treating heart attack patients undergoing PCI

Share on Twitter Share on Facebook Share on Linkedin
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
The findings were presented Wednesday, Oct. 14, during TCT Connect 2020. 
READ MORE >

Supplements containing cesium chloride linked to heart toxicity, cardiac arrest, arrhythmias and death, FDA warns

Five companies received warnings from the FDA for illegally selling supplements containing cesium chloride. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Supplements containing cesium chloride linked to heart toxicity, cardiac arrest, arrhythmias and death, FDA warns

Share on Twitter Share on Facebook Share on Linkedin
Five companies received warnings from the FDA for illegally selling supplements containing cesium chloride. 
READ MORE >

Why metoprolol should be the beta-blocker of choice for heart attack patients

While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Why metoprolol should be the beta-blocker of choice for heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.
READ MORE >

Intravascular lithotripsy ‘safely and effectively’ facilitates stent delivery for CAD patients

The findings were presented Thursday, Oct. 15, at TCT Connect 2020.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Intravascular lithotripsy ‘safely and effectively’ facilitates stent delivery for CAD patients

Share on Twitter Share on Facebook Share on Linkedin
The findings were presented Thursday, Oct. 15, at TCT Connect 2020.
READ MORE >

Hydroxychloroquine ‘not an effective treatment’ for COVID-19, leads to longer hospital stays

The study's authors explored data from more than 1,500 patients treated with hydroxychloroquine and more than 3,000 who received usual care. 

READ MORE >
Hospital staff walking through a medical facility, intentionally blurred to look artistic
Share on Twitter Share on Facebook Share on Linkedin

Hydroxychloroquine ‘not an effective treatment’ for COVID-19, leads to longer hospital stays

Share on Twitter Share on Facebook Share on Linkedin
Hospital staff walking through a medical facility, intentionally blurred to look artistic
The study's authors explored data from more than 1,500 patients treated with hydroxychloroquine and more than 3,000 who received usual care. 
READ MORE >

How to prepare for a COVID-related medical malpractice crisis

The ongoing pandemic has already created countless challenges for healthcare providers—and a medical malpractice crisis could be next.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

How to prepare for a COVID-related medical malpractice crisis

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The ongoing pandemic has already created countless challenges for healthcare providers—and a medical malpractice crisis could be next.
READ MORE >

Valve durability after 5 years: Sapien 3 TAVR outcomes comparable to SAVR

The Sapien 3 prosthesis continues to impress, though researchers must continue to monitor its performance as time goes on.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Valve durability after 5 years: Sapien 3 TAVR outcomes comparable to SAVR

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
The Sapien 3 prosthesis continues to impress, though researchers must continue to monitor its performance as time goes on.
READ MORE >

Medtronic announces 2 new TAVR studies, including a head-to-head comparison of Evolut Pro and Sapien 3

A new feasibility study focused on additional patient populations is also in the works.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Medtronic announces 2 new TAVR studies, including a head-to-head comparison of Evolut Pro and Sapien 3

Share on Twitter Share on Facebook Share on Linkedin
A new feasibility study focused on additional patient populations is also in the works.
READ MORE >

The pandemic’s toll: Total deaths, death from heart disease both up in the US

Total death counts in the United States are typically consistent from one year to the next, the authors noted—but not in 2020. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

The pandemic’s toll: Total deaths, death from heart disease both up in the US

Share on Twitter Share on Facebook Share on Linkedin
Total death counts in the United States are typically consistent from one year to the next, the authors noted—but not in 2020. 
READ MORE >

TAVR safe for low-risk patients with bicuspid aortic valve disease

More research on long-term outcomes is still needed before TAVR can be recommended for such patients across the board.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR safe for low-risk patients with bicuspid aortic valve disease

Share on Twitter Share on Facebook Share on Linkedin
More research on long-term outcomes is still needed before TAVR can be recommended for such patients across the board.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib
News Alert: FDA shares new warning about Impella heart pumps after death

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme